Elkridge, MD, United States of America

Thomas E Uveges

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Thomas E Uveges: Innovator in Bone Repair Technologies

Introduction

Thomas E Uveges is a notable inventor based in Elkridge, MD (US). He has made significant contributions to the field of bone repair, holding a total of 3 patents. His work focuses on innovative solutions for treating bone defects, showcasing his expertise and dedication to advancing medical technology.

Latest Patents

Among his latest patents is a bone repair product and methods of use thereof. This invention provides a bone repair composition that includes periosteum containing angiogenic growth factors, cancellous bone chips with viable osteogenic cells, and optionally, demineralized bone matrix (DBM) chips. The patent outlines articles of manufacture and methods for using this composition to effectively treat bone defects.

Career Highlights

Thomas E Uveges is currently associated with Osiris Therapeutics, Inc., where he continues to develop and refine his innovative ideas. His work at Osiris Therapeutics has positioned him as a key player in the field of regenerative medicine, particularly in the area of bone repair.

Collaborations

He has collaborated with notable colleagues such as Jin-Qiang Kuang and Alla Danilkovitch, contributing to a dynamic research environment that fosters innovation and development in medical technologies.

Conclusion

Thomas E Uveges exemplifies the spirit of innovation in the medical field, particularly through his advancements in bone repair technologies. His contributions are paving the way for improved treatment options for patients with bone defects.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…